Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
M. Hill
Observed name:
M E Hill
Institution:
University of Birmingham
Observed institutions:
Queen Elizabeth Hospital Birmingham,
Selly Oak Hospital,
University of Birmingham
OpenAlex ID:
A5113676840
Cardiopulmonary resuscitation: who makes the decision?
1994
·
M E Hill
, G MacQuillan
, et al.
·
BMJ
·
62
British Thoracic Oncology Group Trial, BTOG2: Randomised phase III clinical trial of gemcitabine combined with cisplatin 50 mg/m2 (GC50) vs cisplatin 80 mg/m2 (GC80) vs carboplatin AUC 6 (GCb6) in advanced NSCLC
2011
·
D. Ferry
, L. J. Billingham
, et al.
·
Thorax
·
15
PDF
Sulfasalazine induced seizures and dysphasia.
1994
·
M E Hill
, C Gordon
, et al.
·
PubMed
·
15
Quality of life in advanced non-small cell lung cancer, effects of cisplatin dose and carboplatin in combination with gemcitabine: results from BTOG2, a British Thoracic Oncology Group phase III trial in 1363 patients
2011
·
L. J. Billingham
, P. Gaunt
, et al.
·
Thorax
·
7
PDF
Day case cisplatin delivery for advanced NSCLC patients: faster, cheaper, more desirable
2011
·
H. Jarrett
, M. Hill
, et al.
·
Thorax
·
3
PDF
The value of routine serum carcino-embryonic antigen measurement and computed tomography in the surveillance of patients after adjuvant chemotherapy for colorectal cancer: analysis from a prospective randomised controlled trial
2003
·
I. Chau
, M.J. Allen
, et al.
·
European Journal of Cancer Supplements
·
1
A MR-based IGRT platform using the KPC transgenic mouse model of pancreatic cancer
2016
·
J. Thompson
, J. Beech
, et al.
·
Radiotherapy and Oncology
Show more works
View as search
Works count:
7
Citation count:
103
H-index:
4
I10-index:
3
Year
Topic
Type